Recent Updates
Recently added Catalysts
RDY Positive Sentiment Score: 70/100

Dr. Reddy's Laboratories Ltd . 8-2-337, Road No. 3, Banjara Hills Hyderabad - 500 034, Telangana, India CIN: L85195TG1984PLC004507 Tel: + 91 40 4900 2900 Fax: + 91 40 4900 2999 Email: mail@drreddys.com Web: www.drreddys.

Key Takeaway: Dr. Reddy's Laboratories Ltd. has announced the allotment of 9,165 equity shares to employees following the exercise of stock options under its established Employee Stock Options Scheme. This transaction took place on December 9, 2025, and is in line with the SEBI regulations. The company's commitment to employee opportunities and compliance with regulations reflects its strong governance practices.

Market Sentiment Analysis

POSITIVE FACTORS

  • Dr. Reddy's Laboratories has successfully allotted equity shares to employees, indicating good corporate governance.
  • The exercise of stock options shows employee engagement and potential growth in shareholder value.
  • The company complies with SEBI regulations, which reflects transparency and adherence to regulatory standards.

Full Press Release Details

National Stock Exchange of India Ltd. (Scrip Code: DRREDDY)
BSE Ltd. (Scrip Code: 500124)
New York Stock Exchange Inc. (Stock Code: RDY)
NSE IFSC Ltd. (Stock Code: DRREDDY)
Sub: Allotment of Equity Shares on exercise of Stock Options under ESOPs
This is to inform you that the Company has allotted 9,165 equity shares of Re.1/- each of the Company, fully paid up, on December 9, 2025, to eligible employees pursuant to exercise of their Stock Options under Dr. Reddy's Employees Stock Options Scheme, 2002 and Dr. Reddy's Employees ADR Stock Options Scheme, 2007.
Further, please find enclosed the details as required under Regulation 10(c) of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.
For Dr. Reddy's Laboratories Limited
Company Secretary, Compliance Officer & Head-CSR
Details under Regulation 10(c) of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021
1 Company name and address of Registered Office: Dr. Reddy's Laboratories Limited 8-2-337, Road No.3, Banjara Hills, Hyderabad - 500034
2 Name of the Stock Exchanges on which the company's shares are listed: BSE Limited National Stock Exchange of India Limited New York Stock Exchange Inc. (ADRs) NSE IFSC Limited (ADRs)
3 Filing date of the statement referred in Regulation 10(b) of the SEBI (Share Based Employee Benefits) Regulations, 2021 with Stock Exchange: The Schemes were institutionalised under the erstwhile the SEBI (Employee Stock Option Scheme and Employee Stock Purchase Scheme) Guidelines, 1999 and appropriate details under Schedule V were filed. The Schemes comply with provisions of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations , 2021.
4 Filing Number, if any: NA
5 Title of the Scheme pursuant to which shares are issued, if any: Dr. Reddy's Employees Stock Options Scheme, 2002 and Dr. Reddy's Employees ADR Stock Option Scheme, 2007.
6 Kind of security to be listed: Equity Shares
7 Par value of the shares: Re. 1/-
8 Date of issue of shares: December 9, 2025 (Date of allotment on exercise)
9 Number of shares issued: 9,165 equity shares
10 Share Certificate No., if applicable: NA
11 Distinctive number of the share, if applicable: 834621191 to 834630355
12 ISIN Number of the shares if issued in Demat: INE089A01031
13 Exercise price per share: i. 4,890 equity shares exercised at Re.1/- per share ii. 2,000 equity shares exercised at Rs. 562.80/- per share iii. 2.275 equity shares exercised at Rs. 735.80/- per share
14 Premium per share: i. 4,890 equity shares- Nil ii. 2,000 equity shares- Rs. 561.80/- per share iii. 2,275 equity shares-Rs.734.80/- per share
15 Total Issued shares after this issue: 83,46,31,355 (*)
16 Total Issued share capital after this issue: Rs. 83,46,31,355 /-
17 Details of any lock-in on the shares: NA
18 Date of expiry of lock-in: NA
19 Whether shares identical in all respects to existing shares if not, when will they become identical? Yes, the shares rank pari passu with the existing shares
20 Details of listing fees, if payable: NA
(*) Total paid up capital after this issue: 83,46,30,355 equity shares of Re.1 each, aggregating to Rs. 83,46,30,355/- (difference of 1,000 due to forfeited shares of Re. 1/- each in September 1988 on account of non-payment of allotment money.)

Frequently Asked Questions

When were the equity shares allotted to employees?

The equity shares were allotted on December 9, 2025.

How many equity shares were issued under the ESOP?

A total of 9,165 equity shares were issued.

What is the par value of the shares issued?

The par value of the shares is Re. 1/- each.

What schemes are related to the equity shares allotment?

The allotment is under two schemes: 2002 and 2007 ESOPs.

Are the newly issued shares identical to existing shares?

Yes, the new shares rank pari passu with existing shares.

Last updated: Dec 9, 2025